AN2 THERAPEUTICS INC (ANTX) Stock Balance Sheet
NASDAQ:ANTX - Nasdaq - US0373261058 - Common Stock - Currency: USD
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 33.50M | 15.65M | 27.20M | 12.10M | 4.10M | |||
| Marketable Securities | 59.92M | 91.65M | 68.80M | 46.50M | 0.00 | |||
| Other Current Assets | 4.26M | 3.21M | 2.60M | 1.60M | 200.00K | |||
| Total Current Assets | 97.69M | 110.51M | 98.60M | 60.10M | 4.20M | |||
| Non-Current Assets | ||||||||
| Investments And Advances | 0.00 | 27.19M | 3.20M | 3.50M | 0.00 | |||
| Other Non-Current Assets | 0.00 | 1.04M | 700.00K | 1.70M | 0.00 | |||
| Total Non-Current Assets | 0.00 | 28.24M | 4.00M | 5.20M | 0.00 | |||
| TOTAL ASSETS | 97.69M | 138.74M | 102.60M | 65.30M | 4.20M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | 0.00 | 10.00K | |||
| Accrued Expenses | 7.03M | 10.70M | 5.10M | 2.30M | 1.30M | |||
| Accounts Payable | 1.71M | 2.68M | 2.10M | 1.10M | 100.00K | |||
| Other Current Liabilities | 1.27M | 668.00K | 0.00 | N/A | 0.00 | |||
| Total Current Liabilities | 10.02M | 14.04M | 7.20M | 3.40M | 1.50M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | N/A | 0.00 | 0.00 | N/A | 0.00 | |||
| Total Non-Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| TOTAL LIABILITIES | 10.02M | 14.04M | 7.20M | 3.40M | 1.50M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -198.25M | -154.46M | -89.70M | -47.40M | -20.30M | |||
| Additional Paid In Capital | 285.81M | 278.88M | 185.50M | N/A | N/A | |||
| Common Shares | 300.00 | 300.00 | 0.00 | 109.30M | 23.10M | |||
| Other Shareholders' Equity | -300.00 | -300.00 | 0.00 | N/A | N/A | |||
| Shares Outstanding | 29.87M | 29.74M | 19.40M | 18.70M | 18.70M | |||
| Tangible Book Value per Share | 2.94 | 4.19 | 4.92 | -2.53 | -1.09 | |||
| Total Shareholders' Equity | 87.67M | 124.70M | 95.40M | 61.90M | 2.80M | |||
| TOTAL LIABILITIES AND EQUITY | 97.69M | 138.74M | 102.60M | 65.30M | 4.20M | |||
| Statistics | ||||||||
| Current Ratio | 9.75 | 7.87 | 13.69 | 17.68 | 2.80 | |||
| Return On Assets (ROA) | -62.13% | -46.66% | -41.70% | -42.97% | -347.14% | |||
| Return On Equity (ROE) | -69.23% | -51.91% | -44.84% | -45.33% | -520.71% | |||
All data in USD , ROIC based on taxRate of 0.21